Philip Jull
Vorsitzender bei ARROW EXPLORATION CORP.
Vermögen: 2 Mio $ am 31.05.2024
Aktive Positionen von Philip Jull
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARROW EXPLORATION CORP. | Vorsitzender | 21.03.2020 | - |
TRYPTAMINE THERAPEUTICS LIMITED | Vorsitzender | - | - |
Direktor/Vorstandsmitglied | 25.09.2020 | - | |
Independent Dir/Board Member | 25.09.2020 | - | |
GENETETHER THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 01.10.2021 | - |
Independent Dir/Board Member | 01.10.2021 | - | |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Philip Jull
Ehemalige bekannte Positionen von Philip Jull
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Vorsitzender | 01.11.2015 | 01.01.2022 |
Gründer | 01.11.2015 | 01.01.2022 | |
Research Capital Corp.
Research Capital Corp. Investment ManagersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Corporate Officer/Principal | 01.08.2004 | 01.11.2015 |
ALDRIDGE MINERALS INC. | Direktor/Vorstandsmitglied | 12.12.2017 | - |
Independent Dir/Board Member | 12.12.2017 | - |
Ausbildung von Philip Jull
University of Toronto | Undergraduate Degree |
University of Western Ontario | Masters Business Admin |
Statistik
International
Kanada | 9 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 5 |
Chairman | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ARROW EXPLORATION CORP. | Energy Minerals |
GENETETHER THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Finance |
Aldridge Minerals, Inc.
Aldridge Minerals, Inc. Precious MetalsNon-Energy Minerals Aldridge Minerals, Inc. is a development stage mining company. It engages in the business of identifying, acquiring, exploring, and developing mineral properties. The company was founded on June 6, 1994 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Research Capital Corp.
Research Capital Corp. Investment ManagersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Finance |
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
- Börse
- Insiders
- Philip Jull
- Erfahrung